financetom
Business
financetom
/
Business
/
NYT sends AI startup Perplexity 'cease and desist' notice over content use
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NYT sends AI startup Perplexity 'cease and desist' notice over content use
Oct 15, 2024 10:48 PM

Oct 15 (Reuters) - The New York Times ( NYT ) has sent

Perplexity a "cease and desist" notice demanding the company

stop using the newspaper's content for generative AI purposes,

the startup said on Tuesday, marking the latest clash between

the news publisher and an AI firm.

The news publisher said in the letter, a copy of which it

shared with Reuters, that the way Perplexity was using its

content, including to create summaries and other types of

output, violates copyright law. NYT declined to provide

additional comment on the matter.

Since the introduction of ChatGPT, publishers have been

raising the alarm on chatbots that can comb the internet to find

information and create paragraph summaries for the user.

In the letter to Perplexity dated Oct. 2, NYT demanded the

AI firm "immediately cease and desist all current and future

unauthorized access and use of The Times's content."

It also asked Perplexity to provide information on how it is

accessing the publisher's website despite its prevention

efforts.

Perplexity had previously assured publishers it would stop

using "crawling" technology, according to the letter. Despite

this, NYT said its content still appears in Perplexity.

"We are not scraping data for building foundation models,

but rather indexing web pages and surfacing factual content as

citations to inform responses when a user asks a question,"

Perplexity told Reuters.

The startup also said it plans to respond by an Oct. 30

deadline set by NYT to provide the requested information.

NYT is also tussling with OpenAI, which it had sued late

last year, accusing the firm of using millions of its newspaper

articles without permission to train its AI chatbot.

Earlier this year, Reuters reported multiple AI companies

were bypassing a web standard used by publishers to block the

scraping of their data used in generative AI systems.

Perplexity faced accusations from media organizations such

as Forbes and Wired for plagiarizing their content, but has

since launched a revenue-sharing program to address some

concerns put forward by publishers.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Turkey's Pasifik Eurasia, China Railway unit sign rail transport deal
Turkey's Pasifik Eurasia, China Railway unit sign rail transport deal
Jun 18, 2025
ISTANBUL, June 18 (Reuters) - Pasifik Eurasia Lojistik said it has signed a railway transport agreement with a subsidiary of China Railway to launch cargo train services along a corridor from China passing through Turkey into Europe, bypassing Russia. Ten train services will be operated initially, with the goal of reaching 1,000 services per year. The partnership with the state-owned...
Top Premarket Decliners
Top Premarket Decliners
Jun 18, 2025
07:45 AM EDT, 06/18/2025 (MT Newswires) -- CERo Therapeutics ( CERO ) shares were 27% lower pre-bell Wednesday, paring Tuesday's rally. Borealis Foods ( BRLS ) stock was down 22% following a 6.6% increase in the previous session. Eyenovia ( EYEN ) shares were 16% lower, shaving gains from the previous session. Regencell Bioscience ( RGC ) stock was down...
Senti Bio Receives US FDA Orphan Drug Designation for Potential Blood Cancer Treatment
Senti Bio Receives US FDA Orphan Drug Designation for Potential Blood Cancer Treatment
Jun 18, 2025
07:46 AM EDT, 06/18/2025 (MT Newswires) -- Senti Biosciences ( SNTI ) said Wednesday that the US Food and Drug Administration has granted orphan drug designation for SENTI-202, a drug candidate for relapsed or refractory acute myeloid leukemia. The experimental drug is a first, off-the-shelf cancer immunotherapy natural killer cell treatment designed to target acute myeloid leukemia and other hematologic...
Copyright 2023-2026 - www.financetom.com All Rights Reserved